NuScale's sales fell 99%, and its gross margin went negative
NuScale's sales collapsed 99% in the quarter to June 30, 2026, to $75.00 K from $8.05 M. Management blames the end of "the Fluor FEED Phase 2 engineering services in support of the RoPower project, which was completed in late 2025, with no comparable activity in 2026." Then it got worse: a price agreement with Fluor cut revenue by $176 thousand, "resulting in a negative gross margin." Gross profit was a loss of $152.00 K. The one Romanian project that produced real engineering revenue is finished, and nothing has replaced it.
So what is NuScale spending on with no revenue to speak of? Research and development rose to $18.43 M from $11.80 M, which management ties to "increased activities to advance the technological readiness and design maturity of our NPM components." General and administrative costs reached $26.88 M, the largest expense. Other expenses of $18.55 M rose partly because engineers worked "on fewer commercial projects than in the prior year," so their time no longer lands in cost of sales. The core business lost $64.00 M; investment income trimmed that to a $50.06 M net loss.
For investors, this is a research lab financed by shareholders, with each share losing $0.13 this quarter. Interest on the cash pile is now doing more for the bottom line than the customers are: $13.94 M against $75.00 K of sales. That cannot last, because the pile shrinks with every quarter of losses and every ENTRA1 milestone. Watch for a revenue line that is not a leftover from Romania. Will the first binding order from ENTRA1 arrive before the next tranche of its fee does?

